Which is why I'm excited about B. Once the trial is over in a few months we should have partnership offers. A post a couple weeks ago detailed what other companies have gotten for antibiotics...a free months and we will be good.
Although I would like to see 1.6 again so I can buy more.
Considering what's on the table here in terms of human trials and CTIX's pipeline of drugs, I don't think dilution at present rate is of major concern.
News 
Market Data 
Discover 
AI
